Inhibitor Therapeutics held annual shareholder meeting, elected directors
Inhibitor Therapeutics held its annual stockholders meeting on Sept. 15, 2026. Stockholders selected six directors for one-year terms expiring at the 2027 annual meeting. Cherry Bekaert was ratified as independent registered public accounting firm for the fiscal year ending Dec. 31, 2026. Stockholders adopted the 2025